Ligand Pharmaceuticals (LGND) Curent Deferred Tax Liability (2012 - 2015)

Ligand Pharmaceuticals' Curent Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $258000.0 for Q1 2015.

• In Q1 2015, Curent Deferred Tax Liability fell 83.61% year-over-year to $258000.0; the TTM figure through Mar 2015 stood at $258000.0 (down 83.61% YoY), while the FY2014 annual figure was $257000.0, down 83.67% from the prior year.
• Curent Deferred Tax Liability came in at $258000.0 for Q1 2015 at Ligand Pharmaceuticals, roughly flat from $257000.0 in the prior quarter.
• In the past five years, Curent Deferred Tax Liability ranged from a high of $1.6 million in Q4 2012 to a low of $257000.0 in Q4 2014.
• A 4-year average of $1.3 million and a median of $1.6 million in 2013 frame the typical range for Curent Deferred Tax Liability.
• Across the five-year window, Curent Deferred Tax Liability decreased 0.44% in 2013 and tumbled 83.67% in 2014, its largest moves.
• Ligand Pharmaceuticals' Curent Deferred Tax Liability stood at $1.6 million in 2012, then fell by 0.44% to $1.6 million in 2013, then sank by 83.67% to $257000.0 in 2014, then advanced by 0.39% to $258000.0 in 2015.
• According to Business Quant data, Curent Deferred Tax Liability over the past three periods registered $258000.0, $257000.0, and $1.6 million for Q1 2015, Q4 2014, and Q3 2014 respectively.

Peer Comparison